搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
最新
最佳匹配
资讯
2 小时
Stifel 重申 Apogee Therapeutics 股票买入评级,看好特应性皮炎数据
Investing.com - Stifel 在 Apogee Therapeutics Inc (NASDAQ: APGE) 近期发布的特应性皮炎 (AD)治疗药物 APG777 的 2a 期数据后,重申了其买入评级和 95.00 美元的目标价。根据 InvestingPro 数据,分析师目标价在 78 美元至 116 美元之间,整体共识为强烈买入推荐。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Central Texas flash floods
Trump admin sues California
Death ruled a homicide
Former Gov. DiPrete dies
Barbie with Type 1 diabetes
5-yr extension w/ Thunder
Six agents suspended
14th Wimbledon semifinal
Interim NASA administrator
Booker gets max extension
Greece blocks asylum claims
Cyclist LeMond honored
Cases hit highest level
Copper tariffs to begin Aug 1
Hiker dies in Grand Canyon
Los Angeles joins ACLU suit
US sanctions UN official
Confirmed to lead FAA
Loan interest to restart
Makes first visit to Asia
Bitcoin hits record high
Sinner defeats Shelton
Utah judge sets execution
Cracker sandwiches recalled
Ex-Jazz coach, GM dies
Harvard faces subpoenas
Malaysia’s ex-PM turns 100
Won't revive immigration law
Sentenced to 8+ years
Tunnel collapses in LA
Ex-doctor refuses to answer
Suffers serious injuries
X CEO resigns
To release web browser
反馈